MindMed to Present at Web Summit on Future of Mental Health
NEW YORK , Nov. 1, 2021 /PRNewswire/ — Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ) (the “Company”), a leading biotech company developing psychedelic-inspired therapies, is pleased to announce that CEO Robert Barrow will be speaking at Web Summit , taking place on November 1-4, 2021 in Lisbon, Portugal . Barrow will be interviewed at 11:45am WET on November 3 on the topic, ” Therapy 2.0 – The next step in […]
Small Pharma Reports Second Quarter Highlights
Company advances ongoing clinical trials with Phase I completed and dosing initiated in Phase IIa trial for lead product candidate, SPL026, a DMT-assisted therapy for the treatment of Major Depressive Disorder Fast-track Innovation Passport Designation awarded by the MHRA for SPL026 Successful upgrade to the OTCQB(R) and DTC eligibility Small Pharma Inc. (TSXV: DMT) (OTCQB: […]
